Correlates of skin-related quality of life (QoL) in those with multiple keratinocyte carcinomas (KCs): A cross-sectional study

Siegel, Julia A.; Chren, Mary‐Margaret; Weinstock, Martin A.; Marcolivio, Kimberly; Chen, Shuo; Dellavalle, Robert P.; Warshaw, Erin M.; DiGiovanna, John J.; Ferguson, Ryan; Lew, Robert A.; Ringer, Robert J.; Yoon, Jean; Phibbs, Ciaran S.; Kraemer, Ken; Hogan, Daniel J.; Eilers, David; Swetter, Susan M.; Jacob, Sharon E.; Romero, Laura; Stricklin, George P.; Konnikov, Nellie; Werth, Victoria P.; Sidhu-Malik, Navjeet; Keri, Jonette; Swan, James; Nord, Kristin M.; Pollack, Brian P.; Kempiak, Stephen; High, Whitney A.; Fett, Nicole; Hall, Russell P.; Alonso‐Llamazares, Javier; Rodriguez, Georgette; Sisler, Lorine; O’Sullivan, Mary; Wilson, Sonya G.; Agrawal, Madhuri; Bartenfeld, Debra; Nicalo, Keith; Johnson, Deb; Parks, P; Bidek, Barbara; Boyd, Nancy G.; Watson, Barbara; Wolfe, Dianne; Zacheis, Mark; Okawa, Joyce; Iannacchione, Mary Ann; Quintero, Jalima; Cuddapah, Subbarayudu; Müller, Karen Reetz; Lichon, Vanessa; Anhalt, Todd; Khosravi, Vista; Rahman, Zakia; Lawley, Leslie P.; McCoy, Roberta; Foman, Neal; Bershow, Andrea; Zic, John A.; Miller, Jami L.; Arbuckle, H. Alan; Hemphill, Linnea; Fujita, Mayumi; Norris, David A.; Ramaswamy, Preethi; Nevas, Jennifer; Rao, Caroline H; Gifford, Allen J.; Asher, Kelly A.; Cardones, Adela R.; Richardson, Angela F.; Patrick, Carmen Adams; Fiore, Louis D.; Thwin, Soe Soe; Kebabian, Clara E.; Pavao, Jennifer; Sather, Mike R.; Fye, Carol L.; Hunt, David; Robinson‐Bostom, Leslie; Telang, Gladys H.; Wilkel, Caroline S.; Haynes, Harley A.; Brookhart, M. Alan; Mostow, Eliot N.; Rector, Thomas S.

doi:10.1016/j.jaad.2016.05.008

Cited by 6 publications

(7 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…There were publications on comorbidities in SC patients, HRQoL after treatment and many studies dedicated to different aspects of QoL in different populations of SC patients including studies on behaviour modification, predictors of QoL, predictors of survival, supportive care needs, coping strategies and fear of cancer recurrence…”

Section: Resultsmentioning

confidence: 99%

Quality of life measurement in skin cancer patients: literature review and position paper of the European Academy of Dermatology and Venereology Task Forces on Quality of Life and Patient Oriented Outcomes, Melanoma and Non‐Melanoma Skin Cancer

Chernyshov

Lallas

Tómas-Aragonés

et al. 2019

Acad Dermatol Venereol

View full text Add to dashboard Cite

The European Academy of Dermatology and Venereology (EADV) Task Forces (TFs) on Quality of Life (QoL) and Patient Oriented Outcomes, Melanoma and Non-Melanoma Skin Cancer (NMSC) present a review of the literature and position statement on health-related (HR) QoL assessment in skin cancer patients. A literature search was carried out to identify publications since 1980 that included information about the impact of SC on QoL. Generic, dermatology-specific, cancer-specific, SC-specific, facial SC-specific, NMSC-specific, basal cell carcinoma-specific and melanoma-specific QoL questionnaires have been used to assess HRQoL in SC patients. HRQoL was assessed in the context of creation and validation of the HRQoL instruments, clinical trials, comparison of QoL in SC and other cancers, other diseases or controls, HRQoL assessment after treatment, comorbidities, behaviour modification, predictors of QoL and survival, supportive care needs, coping strategies and fear of cancer recurrence. The most widely used instruments for HRQoL assessment in SC patients are the European Organisation for Research and Treatment of Cancer Core Questionnaire (EORTC QLQ-C30), the Functional Assessment of Cancer Therapy-Melanoma (FACT-M), Skin Cancer Index (SCI), ShortForm 36 Item Health Survey (SF-36) and the Dermatology Life Quality Index (DLQI). The TFs recommend the use of the cancer-specific EORTC QLQ-C30, especially in late stages of disease, and the melanoma-specific FACT-M and SCspecific SCI questionnaires. These instruments have been well validated and used in several studies. Other HRQoL instruments, also with good basic validation, are not currently recommended because the experience of their use is too limited. Dermatology-specific HRQoL instruments can be used to assess the impact of skin-related problems in SC. The

show abstract

Section: Resultsmentioning

confidence: 99%

Quality of life measurement in skin cancer patients: literature review and position paper of the European Academy of Dermatology and Venereology Task Forces on Quality of Life and Patient Oriented Outcomes, Melanoma and Non‐Melanoma Skin Cancer

Chernyshov

Lallas

Tómas-Aragonés

et al. 2019

Acad Dermatol Venereol

View full text Add to dashboard Cite

show abstract

“…34 Siegel and colleagues evaluated 930, mostly elderly, male patients, presenting to the VA health care system. 35 The Skindex-29, SCI, and six study-specific questions were administered to each patient. The authors found that worse postoperative QOL was associated with younger age, greater functional impairments, greater comorbidities, increased sun exposure, as well as history of 5-fluorouracil use (presumably a proxy for prior skin carcinoma treatment).…”

Section: Quality Of Life With Nonmelanotic Skin Cancer Treatmentmentioning

confidence: 99%

“…The authors found that worse postoperative QOL was associated with younger age, greater functional impairments, greater comorbidities, increased sun exposure, as well as history of 5-fluorouracil use (presumably a proxy for prior skin carcinoma treatment). 35 For the head and neck area including the face, quality of life following skin cancer treatment is likely to be heavily impacted by the reconstruction. Unfortunately, studies that have utilized HRQOL as the main outcomes measure following skin cancer reconstructive procedures are significantly lacking.…”

Section: Quality Of Life With Nonmelanotic Skin Cancer Treatmentmentioning

confidence: 99%

Quality of Life Studies in Skin Cancer Treatment and Reconstruction

Joseph

2020

Facial Plast Surg

View full text Add to dashboard Cite

Health-related quality of life (HRQOL) is an important measure of patient experience before, during, and after treatment for skin cancers. Over the past 20 years, a variety of generic as well as disease-specific HRQOL instruments have been developed to assess clinical outcomes. Clinical trials have increasingly focused on using HRQOL instruments as outcome measures. Patients with both cutaneous melanoma and nonmelanotic skin cancers have been found to experience improvement in HRQOL following surgical treatment and reconstruction. Individual demographic variables may further predict experience within each of these groups. Increasing use of HRQOL instruments in future studies comparing skin cancer treatments will allow physicians to better understand and optimize patient experiences.

show abstract

“…The very few studies available have shown lower HRQoL in younger patients and a larger improvement in HRQoL after Mohs micrographic surgery in younger vs. older patients. 2 However, we need to use a disease-specific questionnaire, for example that recently developed by Waalboer-Spuij et al 3 Capturing the influence of all aspects of BCC diagnosis and treatment on HRQoL remains necessary. Our group is currently studying HRQoL in a large number of patients with keratinocyte carcinomas (ClinicalTrials.gov NCT04814953).…”

mentioning

confidence: 99%

“…Laura Van Coile iD , 1,2 Evelien Verhaeghe, 1,2 Katia Ongenae, 1 Lieve Brochez 1,2 and Isabelle Hoorens iD 1,2…”

unclassified

Basal cell carcinoma in older adults: how to decide when active surveillance or watchful waiting is appropriate?

et al. 2022

View full text Add to dashboard Cite

Correlates of skin-related quality of life (QoL) in those with multiple keratinocyte carcinomas (KCs): A cross-sectional study

Cited by 6 publications

References 6 publications

Quality of life measurement in skin cancer patients: literature review and position paper of the European Academy of Dermatology and Venereology Task Forces on Quality of Life and Patient Oriented Outcomes, Melanoma and Non‐Melanoma Skin Cancer

Quality of life measurement in skin cancer patients: literature review and position paper of the European Academy of Dermatology and Venereology Task Forces on Quality of Life and Patient Oriented Outcomes, Melanoma and Non‐Melanoma Skin Cancer

Quality of Life Studies in Skin Cancer Treatment and Reconstruction

Basal cell carcinoma in older adults: how to decide when active surveillance or watchful waiting is appropriate?

Contact Info

Product

Resources

About